Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, previously known through OMP-131R10, represents a new monoclonal protein developed to inhibit granulocyte-macrophage colony-stimulating FMS-like tyrosine kinase. Its mode of action depends on selectively attaching to GM-CSF, redu